The vascular surgery team at UCSF Health recently became the first among University of California medical centers to implant a Barostim device to treat heart failure. The team implanted the device in a young woman with the goal of reducing her heart failure symptoms and improving her quality of life.

Barostim is a new, FDA-approved, implantable device that rebalances the autonomic nervous system, with the goal of improving outcomes for heart failure patients with reduced ejection fraction. 

A UCSF team develops a new drug for malaria that could address one of the disease's biggest challenges - the spread of parasites that resist the most commonly-used medications.

Award-winning UCSF mentors Judith Hellman and Tor Neilands share their keys to success: deep commitment, individualized support, empathy, and responsiveness. They emphasize listening, tailoring guidance, and utilizing UCSF’s robust mentoring resources to foster future generations.

Records from millions of patients at University of California health centers found correlations between endometriosis, one of the most common diseases in women, and a bounty of other diseases.

UC San Francisco’s Paul Farmer African Initiative for Research (PFAIR) supports African scientists in infectious disease research via mentorship, international collaboration, and sustainable funding.

UCSF’s Joseph Pierre, MD, unveils why even bright minds embrace false information. His new book, "False," dissects cognitive biases and our digital world’s role, offering a powerful three-step approach to navigate the post-truth era and rediscover common ground.